Table 3.
Clinical trials on apremilast planned, in progress, or completed with results not published in a journal.
| Disease | Study Type | Number of patients (estimated or actual) |
Study Number | Citation |
|---|---|---|---|---|
| Hidradenitis Suppurativa | Open-label | 20 | NCT02695212 a | (56) |
| Nail psoriasis | Open-label | 20 | NCT03022617 | (57) |
| Open-label | 50 | NCT03616561 | (58) | |
| Scalp psoriasis | RCT | 303 | NCT03123471 | (59) |
| RCT | 90 | NCT03553433 | (60) | |
| Female genital erosive lichen planus | RCT | 40 | NCT03656666 | (61) |
| Recurrent aphthous stomatitis | Open-label | 15 | NCT03690544 | (62) |
| Prurigo nodularis | Open-label | 15 | NCT03576287 | (63) |
| Prurigo nodularis | Open-label | 5 | NCT00869089 b | (64) |
| Frontal fibrosing alopecia | Open-label | 20 | NCT03422640 | (65) |
| Central centrifugal cicatricial alopecia | Open-label | 20 | NCT03521687 | (66) |
| Chronic idiopathic pruritus | Open-label | 10 | NCT03239106 | (67) |
| Chronic hand dermatitis | Open-label | 10 | NCT03741933 | (68) |
| Dermatomyositis (as add-on therapy for cutaneous manifestations) | Open-label | 10 | NCT03529955 | (69) |
| Open-label | 5 | NCT01140503 c | (70) | |
| Nummular eczema | RCT | 40 | NCT03160248 | (71) |
| Vitiligo with NB-UVB | Open-label | 20 | NCT03123016 | (72) |
| RCT | 80 | NCT03036995 | (73) |
Abbreviations: NB-UVB: narrow band ultraviolet B; RCT: randomized controlled trial.
a
Study completed but results are unavailable.
b
2 of 5 patients completed trial, in these 2 poor to minimal response to therapy.
c
Study terminated due to slow recruitment of patients.